Biomarker research
Combinatorial BCL2/BCL2L1 expression predicts clinical response to ruxolitinib in myelofibrosis.
Giacomo Coltro, Viola Videschi, Francesca Gesullo, Federica Violi, Manjola Balliu, Alessandro M Vannucchi, Paola Guglielmelli
Published: 202510.1186/s40364-025-00865-0
No abstract available for this study.